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Summary 
Tonsillar germinal center and immunoglobulin M + (IgM+)IgD + B cells as well as peripheral 
blood (PB) CD5 + and CD5-  (conventional) B cells from a 4-yr-old child were isolated  and 
nudeotide sequences of expressed Ig heavy chain variable regions encoded by V.4 gene family 
members were determined from amplified cDNA. Whereas both tonsiUar IgM +  IgD + cells and 
the majority of IgM-expressing CD5 +  and CD5-  PB  B  cells showed no or little somatic 
mutation, tonsillar germinal center (GC) B cells and IgG-expressing PB B cells carried a high 
load of somatic mutations in their V region genes. This suggests that somatically mutated memory 
B cells which have switched isotype accumulate in the PB already at young age. Their frequency 
seems to increase with age. On the other hand, the antibody repertoire of tonsillar IgM+IgD + 
B  cells and the majority of IgM-expressing PB B  cells is determined by germline-encoded 
specificities and by generation of variability in the complementary  determining region III through 
VH-D,-J. recombination. A fraction of IgM-bearing PB B cells carries somatically mutated V 
region genes and probably represents GC-derived B cells which have left the GC at an early 
stage of the GC reaction without undergoing isotype switching. 10 V.4 germline genes were 
found to be expressed.  Three gene segments were overrepresented  in the sequence collection 
(35  of 50 clones):  V,4.21  (30%),  V71-4  (20%),  and 3D279D  (20%).  It appears  that most 
potentially functional V,4 germline genes are expressed in peripheral B cells. Some members 
of this V. gene family are dearly overrepresented over others. 
I 
mmunoglobulin heavy chain V region genes expressed by 
B lymphocytes are generated by assembling V., DH/D~ 
irregular recombination signal (DIK), and JH gene segments 
during B cell development in the bone marrow (1, 2). The 
descendants of newly formed B cells in the bone marrow, 
IgM +  IgD + "naive" B cells, mostly express unmutated V re- 
gion genes (3, 4) and are considered precursors of germinal 
center B cells (GCC) 1 that participate in T  cell-dependent 
immune responses to exogenous antigens (5, 6). In the course 
of a germinal center (GC) reaction, B cells hypermutate their 
V region genes (7-9). Mutants that exhibit a higher a~nity 
to their target antigen are selected (8, 10) and are subsequently 
released into the periphery as long-lived memory B cells most 
of which have switched isotype (11). 
Over the last years, many studies in humans focused on 
rearranged V region genes in malignant and autoimmune B 
cells. Only recently has the normal B cell repertoire become 
1 Abbreviations used in thispaper: FRI, framework region I; GC, germinal 
center; GCC, germinal center B cell; PB, peripheral blood; P/B/A, PBS, 
BSA, sodium azide;  PNA, peanut agglutinin. 
a subject of investigation. The analysis of secondary immune 
responses  to defined antigens showed that IgG-expressing 
(memory) B cells carry somatically mutated V region genes 
(12, 13). Also, the majority of isotype-switched B cells de. 
rived from the peripheral blood (PB) of adults show a high 
level of somatic mutation (4,  14), mirroring the situation 
in the mouse spleen (15). 
At the time of birth, IgM-bearing B cells from cord blood 
carry virtually unmutated V region genes (16, 17). In con- 
trast, a portion of IgM-expressing PB B cells derived from 
adults express mutated V region genes (16, 18,  19). These 
cells most likely represent IgM+IgD- B cells which consti- 
tute a minor fraction of IgM-expressing PB B cells (4). Results 
obtained by Ebeling et al. (20) suggest that the vast majority 
of tonsillar B lymphocytes express somatically mutated anti- 
bodies. However, mantle zone B cells (which surround GCs 
and most of which are IgD positive)  derived from lymph 
nodes carry V regions that show no or little somatic muta- 
tion (9). 
Most of the previous studies focused on the analysis of only 
a single B cell subpopulation and were performed on tissue 
or blood samples derived from donors of various ages. There- 
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of cellular maturation derived from a single individual at the 
level of rearranged V genes. This allowed us to compare the 
extent of somatic hypermutation in V region genes as well 
as V gene usage between subpopulations. The analysis com- 
prised naive IgM+IgD + B cells, GCC, and IgG- (memory) 
as well as IgM-expressing PB B cells. PB B cells were sepa- 
rated into conventional (CD5-) and CD5 + B cells, the latter 
representing the majority (about 70%) of PB B lymphocytes 
in young children, their percentage declining in the course 
of life (20-30%  in the adult) (21). 
As an additional point, we investigated whether GCC and 
GC-derived (memory) B cell subsets derived from a child al- 
ready show the characteristics of the same subsets in the adult, 
namely a high load of somatic mutations in their rearranged 
V genes. Results obtained by Mortari et al. (22) suggest that 
the hypermutation mechanism is already active  at birth. 
The analysis concentrated on rearranged V region genes 
of the V.4 gene family (23) that has been extensively charac- 
terized in recent years (24-30) and seems to consist of about 
10-12 genes/haploid genome (26,  29, 30).  Members of the 
V,4 gene family have been found expressed in both mutated 
and unmutated form. V,4 gene segments were found to be 
rearranged in various B cell subsets. Overall, the V~4 family 
seems to be suitable to analyze B cell subsets for somatic mu- 
tation. 
Materials and Methods 
CellPreparation.  Tonsils  obtained from a routine tonsillectomy 
of a 4-yr-old child and PB from the same patient were provided 
by the Hals-Nasen-Ohren-Klinik of the Cologne University Hos- 
pital. The child suffered from recurrent tonsillitis and was other- 
wise healthy. Tonsillar cell suspensions were obtained by mincing 
the tissue in ice-cold  culture medium (KPMI-1640; GIBCO BILL, 
D~sseldorf, Germany)  and pressing  it through a stainless  steel sieve. 
Mononuclear cells  were isohted by Ficoll (Histopaque 1077; Sigma, 
Deisenhofen, Germany)  gradient centrifugation performed at 4~ 
PBMC were isohted by Hcoll gradient centrifugation  of  heparinized 
blood at room temperature. 
mAbsandLectins.  The following mAbs were used: anti-CD20 
(I.eu16) (IgG1), either as HTC or as PE conjugate, and biotinyhted 
anti-CD5  (Leul) (IgG2a), obtained from Becton Dickinson & 
Co. (Mountain View, CA). Anti-human IgD (IADB6) (IgG2a) 
(Southern Biotechnology Associates, Birmingham, AL) was de- 
veloped in a second staining step by anti-mouse IgG2a/b-HTC 
(Miltenyi  Biotec, Bergisch Gladbach, Germany). Anti-CD3 micro- 
beads (I.eu4) (IgG1), anti-CD14 microbeads (LeuM3) (IgG2a), and 
anti-mouse-IgG2a/b  microbeads (rat IgG1) were obtained from 
Miltenyi  Biotec. The lectin peanut agghtinin (PNA) was purchased 
as a FITC conjugate from Vector Laboratories, Inc. (Burlingame, 
CA). Streptavidin-PE was from Becton Dickinson & Co. 
Cell Separation.  GCC and IgD + B cells were enriched  by mag- 
netic cell separation  using the MACS system (Miltenyi  Biotec) (31). 
To  avoid apoptosis of GCC  (6), the  cells were kept  at  4~ 
throughout the separation. 2  x  10  s tonsillar mononuclear cells 
were incubated with anti-CD3 mierobeads, anti-CD14 microbeads, 
and anti-IgD for 20 rain. After washing with P/B/A (PBS, 1% 
BSA, 0.02%  sodium  azide), the  cells were incubated  with 
anti-mouse IgG2a/b microbeads for 20 rain. After washing and 
resuspension in 4 ml P/B/A, the cell suspension was  put on top 
of a separation column (C-column; Miltenyi Biotec). All elutions 
were performed with P/B/A. The cells that did not bind to the 
column were eluted with a flow rate of "~6 ral/min ("flow frac- 
tion"). The cells that bound to the column were ehted outside 
the magnetic field with a high flow rate ("microbeads fraction"). 
The flow fraction was incubated with anti-CD20-PE and PNA- 
HTC. The B ceil-specific anti-CD20  antibody (I.eu16) divides 
tonsillar B cells into bright and dim populations, thereby distin- 
guishing between GCC (CD20-bright [CD20++]) and non-GCC 
(representing mantle zone and interfollicular B cells, CD20-dim 
[CD20*]) 02).  The lectin PNA stains GCC more brightly than 
non-GCC (33). Fig. 1 (top left) shows that the CD20 +§ cells were 
also stained by PNA,  further supporting their GC origin.  The 
microbeads fiaction was incubated  with anti-IgD and antiq2D20-PE 
in a first staining step followed, after washing, by incubation with 
anti-mouse-IgG2a/b.  Fig. 1 (bottom  left)  shows that the majority 
of non-GCC (CD20 +) expressed IgD, whereas GCC (CD20 § 
were IgD-negative. GCC (PNA+/CD20 ++) and IgD + B cells 
(IgD +/CD20 +) were enriched on a FACS  |  (model 440; Becton 
Dickinson & Co.) to 99 and 97% purity, respectively (Fig. 1). 
PBMC were incubated with anti-CD20-HTC and biotinyhted 
anti-CD5 followed,  after washing, by incubation with Streptavidin- 
PE.  All stainings were performed for  15  rain  on ice. CDS+/ 
CD20 + and CDS-/CD20 + (conventional) B cells were enriched 
on a FACS  |  440 to 73 and 79% purity, respectively  (Fig. 2). Ap- 
proximately 70% of the B cells expressed the CD5 antigen (Fig. 
2, left). This is in accordance with the observation that the per- 
centage of CD5-positive B cells among CD20 + B cells decreases 
from about 70% in the newborn to about 25% in the adult (21). 
In all sortings, selective  gates were set to exclude  propidium io- 
dide-stained dead ceils and nonlymphocytes  using forward and side 
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Figure  1.  Flow  cytometric  analysis  of tonsillar B cells derived  from a 
4-yr-old child. (top/eft)  PNA/anti-CD20 and (bottom/eft) anti-IgD/anti- 
CD20 doublest~inin~  of  tonsillar  mononuclear  ~  and the corresponding 
reanalyres of (top right) PNA +/CD20  ++ (GCC) and (bottom right) IgD +  / 
CD20 + B cells after  enrichment  by MACS and FACS. Indicated  are the 
windows for the PNA §  +  + and IgD +/CD20  + populations,  respec- 
tively, and their percentages among the mononuclear  cells. 
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determined on a FACScan  |  using Lysis I! software (Becton Dick- 
inson & Co.). 
Since all separation steps involving a positive selection of CD20- 
positive B cells were carried out at 4~  we consider an influence 
on somatic mutation in the isolated B cells unlikely. 
RNA Isolation, Clonin,~ and Sequencing of PCR-amplified  Mate- 
r/al.  Total  cenuh~ KNA was isolated from 3  x  106 cells of each 
the PNA §  §  + and IgD +/CD20 + fractions and from 5  ￿ 
10  s cells of each the CD5+/CD20 § and the CDS-/CD20 + frac- 
tions as described (34). For first strand cDNA synthesis, total cel- 
lular KNA of each fraction was hybridized to a primer specific for 
the first exon of the/~ chain constant region (CK) (Cp.a: 5'-GAG- 
GCAGCTCAGCAATC-Y) and in the case of the PNA+/CD20 +§ 
and CD5-/CD20 + fractions,  also to a primer specific for a se- 
quence  in  the  first  exon  of all  four  y  chain  CKs  (Cya:  5'- 
GACCTTGACCAGGCAGCCCAC~Y) and extended with Super- 
Script MMLV reverse transcriptase (GIBCO BILL). One twentieth 
of each the PNA+/CD20 ++ and IgD*/CD20 § and one fifth of 
each the CDS+/CD20 + and CDS-/CD20 + first strand  eDNA 
mixture was amplified in separate PCK reactions using a C~-ptimer 
specific for a sequence in the first exon of the/~ chain CR (C/zb: 
5'-gg  .gGAATI~TCACAGGAGACGAGGGGGAA-Y)  and  a  5' 
primer specific  for  a  sequence  in  framework region  I  (FILl)  of  V.4 
(9).  The V.4FILl-primer exhibits  100% homology to the corre- 
sponding sequence  in nearly  all  V.4 germline genes published  to 
da~ Only to  some  it  shows  a  single  basopair  mismatch in  the  middle 
of  the  sequence  which should  not  prevent  successful  amplification. 
One  twentieth of the PNA-/CD20 +§ and one fifth  of the 
CD5-/CD20 +cDNA  mixture was amplified  in separate  PCR 
reactions  using the V.4FPd-primer and a 3' primer recognizing 
a  sequence  in  the  first  exon of  all  four  7 chain  CRs (C'yb:  5'-atca- 
g~tcgacKAGACCGATGGC~CCTIGGTGGA-Y).  Genomic DNA 
from 3 x 10  ~  cells  of  the IgD§  + fraction  was isolated  ac- 
cording to standard procedures (35) and one tenth of the mixture 
was PCK amplified with  a J~ primer  mix  (9) and V, primers 
recognizing  a sequence in the FRI of either V,3 or V~4 (4). The 
V~4FKI, C,),b, and the J~ laime~s contained SalI, the C~b, V,3FgI, 
and V,4PKI primers EcoRI restriction  sites for cloning  (under- 
lined). PCK amplification was performed in 50-/~1 reaction mix- 
tures  containing  10 cam Tris-HC1, 50 mM KC1, 1.5 ram MgCh, 
200/zM dNTP, 0.125/~M of each primer,  and 2.5 U Taq Poly- 
merase (GIBCO BILL), and consisted of 40 cycles of 80 s at 95~ 
30 s at 65~  (63~  for the V~ amplification), and 80 s at 72~ 
Taq polymerase was added after the first denaturation  step. All 
amplifications were can~ed out in a Trio Thermoblock (Biometra 
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Figure 2.  Flow  cytometric analysis of PB B cells derived from a 4-yr- 
old child. Anti-CD20/anti-CD5 doublestainings of (/eft) PBMC, (center) 
CDS+/CD20 +, and (right) CDS-/CD20 + conventional B cells. (Left) 
The gates set for sorting of B cells acvo~ing to their CD5 expression 
and the percentages of cells which fell into the gates. (Center and right) 
The con'esponding reanalyses after enrichment by FACS  ~ 
Biomed.  Analytik  GmbH,  Goettingen,  Germany).  Amplified 
eDNA was cloned into pTZ19U by standard methods. After trans- 
formation of Escherichia  coil DH5a, plasmids were isolated using 
the Quiagen Plasmid-Midi-Kit  (Diagen,  Hilden,  Germany).  All 
inserts were sequenced from both sides by the dideoxynudeotide 
termination method with T7 DNA polymerase  (Pham~.~:_~,  F.m3mrg, 
Germany) using the PCK primers described above. Sequences were 
analyzed with DNASIS  TM  software (Pharmacia). 
Results 
Cloning and Sequencing of V~l ~anscripts.  The character- 
ization and purification of the B cell subsets analyzed were 
described in Materials and Methods and are depicted in Figs. 
1 and 2. The insert of 51 individual bacterial colonies were 
sequenced in the VH4 gene analysis.  One insert (IGD7) was 
identified as a hybrid most likely representing a PCK artifact. 
The clones were designated according to the B cell subsets 
from which they were derived, and in the case of the GCC 
and conventional (CDS-) B cells, also according to the im- 
munoglobnlin isotype expressed by the cells. They are: IGD1- 
10,  derived  from  tonsiUar  IgD+  B  cells,  #-e~pressing; 
GCM1-8 and GCG1-8, derived from tonsillar GCC, #- and 
~/-expressing,  respectively;  CD5/1-8,  derived from CD5 + 
PB B cells, #-expressing; and CBM1-8 and CBG1-9, derived 
from conventional (CD5-) PB B cells, #- and y-expressing, 
respectively (Table  I). 
Assignment of V~4 and J, Sequences to Germline Genes. 
V.4 sequences of 50 inserts could be assigned to one of eight 
published V.4 germline genes,  namely either V,4.21  (24), 
V71-4 (36), 3D279D (30), V2-1 (23), V.4.33 (25), V,4.34 
(25),  30216D  (37),  or VIV-4 (38)  (Fig.  3). 
Some of the sequences were more homologous to one an- 
other than to published germline genes and therefore most 
likely correspond to novel genes or alleles  (p3D279D  and 
V~4.33r;  see  below).  Also,  the  V,4  sequence  of done 
CD5/4 might correspond to a previously unidentified V,4 
gene (see bdow). 
The  V.4.21,  V71-4,  V2-1,  and 3D279D  genes or their 
corresponding  alleles  to  which  the  majority  of V.4  se- 
quences obtained in the present analysis could be assigned 
have been identified repeatedly in several analyses,  showing 
either no or little sequence divergence (23-30, 36, 38, 39), 
and also in unmutated form in a large number of antibodies, 
as a search in the EMBL (R.35.0) and GenBank (R77.0) data- 
base libraries revealed. These gene segments appear to be highly 
conserved in the population.  Correspondingly,  the nudeo- 
tide  differences of the  Vx4  sequences which  could be as- 
signed to V.4.21, V71-4, V2-1, or 3D279D most likely rep- 
resent  somatic  mutations.  VIV-4,  3D216D,  V.4.33,  and 
V,4.34 have so far only rarely been identified in VH4 germ- 
line gene analyses or in rearranged V~ genes (25-30, 37, 38, 
40,  41).  To test whether nucleotide differences in V,4 se- 
quences which were mostly homologous to one of the rarely 
identified Vx4 germline genes affect the analysis for somatic 
mutation, mutation frequencies were determined in two ways: 
(a) by considering only V,4 sequences that could be assigned 
to either V,4.21, V71-4, V2-1, or 3D279D; and (b) by con- 
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Transcripts Derived  from Isolated Tonsiilar and PB B Cell 
Subpopulations of a #.F-old Child 
Cell  Clones  VH4  nucl.  O  H  nucl.  sum  of  VN&O  H 
populatlon  diff.  diff.  nu~l.d(ff. 
IGD1  4.21  3  3b  0  3 
IG02*  V71-4  0  4b  0  0 
IG/L~  4.21  1  4b  0  1 
IGD4  W1-4  3  3b  0  3 
Tonstllar  IGD5  4.21  0  6b  0  0 
I90  +  B cells  IGD6  V71-4  2  3b  1  3 
(IGD)  IGO8  4.21  1  3b  0  1 
IGD9  4.21  0  6b  0  0 
ICID10  3D279D  0  4b  0  0 
GO41  3O2790  5  6b  1  6 
GClt2  4.21  3  6<:  0  3 
oao~  v71-4  lO  41)  o  lO 
Ton~tllar  GCH4*  V71-4  2  4b  0  2 
19W  GCC  G(~5  3D279D  3  3b  0  3 
(GCH)  GO~  4.21  7  4b  1  8 
GO47  4.21  5  2  1  6 
(K~B  Ix:qD279D  1  3b  0  1 
GOG1  VlV-4  1  6b  0  1 
GCG2  4.34  3  4b  0  3 
4.33  11  6c  1  12 
Tonal 11 ar  GCG4  p3D279D  7  6c  0  7 
Igg  + GOC  GCGS  4.21  4  4b  0  4 
(GCG)  GCG6  4.33r  13  3b  I  14 
GCG7  30216D  6  4b  0  6 
GCG8  p30279D  13  4b  3  16 
C95/1  p30279D  0  4b  0  0 
CD5/2  V71-4  4  5b  I  5 
(05/3  4.21  3  3b  0  3 
19M  +,  CDS  +  (0514  V71-4  19  5b  0  19 
PB B cells  (05/5  4.21  0  6c  0  0 
((05)  (05/6  4.33  4  4b  1  5 
C05/7  4.21  0  4b  0  0 
(05/8  V2-1  3  4b  0  3 
CBM1  4.21  6  4b  0  6 
CBI42  4.34  2  2  0  2 
C8H3  4.21  3  4b  I  4 
IgH  +,  (05-  C~4  30216D  0  3b  0  0 
PB B cells  C~45  V71-4  1  6b  0  1 
(CBH)  CEN6  VlV-4  11  5b  I  12 
C~47  W1-4  0  4b  0  0 
CBH8  V2-1  2  2  0  2 
C8G1  30279D  2  4b  0  2 
CBG2  4.33r  5  2  1  6 
C8G3  30279D  8  3b  3  11 
C8G4  V2-I  9  4b  I  I 0 
IgG  +,  CDS-  CBG5  4.21  22  4b  4  26 
PB B cells  CBG6  V71-4  10  3b  2  12 
(CBG)  CBG7  V2-1  2  2  0  2 
CG88  p3D279D  1  3b  2  3 
CBG9  V71-4  4  3b  1  5 
Clones are designated as in Fig. 3. Indicated are the V.4 (V.4.21, V71-4, 
3D279D,  V2-1,  V.4.33,  V.4.34,  3D216D  and  VIV-4,  see  Fig.  3; 
V.4.33r and p3D279D, see text) and J. germline genes to which the V.4 
and J. sequences showed highest homology and the nudeotide differences 
to the corresponding germline genes.  The sum of nuclentide differences 
of the combined V.4 and J. sequences is depicted in the right column. 
* Nonproductive rearrangement. 
sidering  all  V.4  sequences  of  a  given  fraction:  IGD, 
0.4%/0.4%; GCM, 2.0%/2.0%; GCG, 3.6%/3.3%; CD5 
(excluding CD5/4), 0.7%/0.8%;  CBM, 0.9%/1.3%;  and 
CBG, 3.4%/3.2%. It turned out that in almost all cases the 
mutation frequency considering all V.4 sequences of a given 
fraction did not differ significantly from that considering only 
V.4  sequences that could be assigned to one of the con- 
served V.4 germline genes. This indicates that most of the 
nucleotide  differences observed in the V.4  sequences that 
showed  highest  homology  to  either  VIV-4,  3D216D, 
V.4.33,  V.4.34,  or V.4.33r,  also represent  somatic  mu- 
tations. 
Five of the six J. germline genes (42, 43) were found to 
be expressed (Table 1). Because of the low level of J. gene 
polymorphism (43) it was possible to unambiguously iden- 
tify somatic mutations in the rearranged J. gene segments. 
V.4 and J. Gene  Usage.  Fig.  3 shows the 50 V.4  se- 
quences obtained from the tonsillar and PB B cell subsets. 
The nudes)tide differences  to the corresponding germline genes 
are depicted in Table 1. 15 V.4 sequences could be assigned 
to Vet.21,  11  to V71-4,  10 to 3D279D,  4  to V2-1,  4 to 
V.4.33,  2 to V.4.34,  2 to 3D216D, and 2 to VIV4 (Fig. 3, 
a-h).  The V.4 sequence of done CD5/4 which differed by 
19 nudeotides from its closest homologue, V71-4, but showed 
no mutations in the rearranged J.5 gene, might correspond 
to  a novel V.4  germline gene on  the assumption  that  a 
highly mutated V region is likely to harbor point mutations 
in rearranged V. as well as J. gene segments. 
Five sequences showed an identical A to G nucleotide ex- 
change at position 3 in codon 69 of 3D279D (Fig. 3 c). This 
shared nucleotide difference presumably represents a V. gene 
sequence polymorphism. Accordingly, the Vet sequence of 
CD5/1 which showed no additional nudeotide differences 
to 3D279D represents a putative novel allele of  this gene seg- 
ment (henceforth designated  as [polymorphic]  p3D279D; 
Table 1).  The V.4  sequences of clones CBG2  and GCG6 
harbored five identical nudeotide exchanges in codons 53, 
67, 73, 74, and 83 of V.4.33, respectively (Fig. 3 e). Since 
it is unlikely that these common nudeotide exchanges were 
introduced by somatic  hypermutation, the V.4 gene seg- 
ment of CBG2  and GCG6 presumably represents either a 
novel aUele of V.4.33 or a previously undescribed Vet germ- 
line gene that is closely related to V.4.33  (henceforth desig- 
nated as V.4.33r [related]; Table 1). 
Considering p3D279D as an aUelic  form of 3D279D  and 
the V.4.33-related  sequence as well as the Vet sequence of 
done CD5/4 as novel genes or duplicates, the number of 
V.4 germline genes expressed in peripheral  B ceils of the 
present individual comes dose to the estimated  10-12 V.4 
germline genes/haploid genome (26,  29, 30). 
20 of the 50 V.4 sequences (40%) carried a rearranged Jet 
gene, 13 a J.3 gene (26~  9 a J.6 (18~  5 a J.2 (10~ 
and 3  a J.5  (6%) (Table 1). J. gene usage did not differ 
siguificantly from that determined  by Sanz (2), Huang et al. 
(14, 18), and Yamada et al. (43) for PB B lymphocytes (Table 
1) when all rearrangements are considered. Jet was dearly 
overrepresented among the 50 clones. 
Overall, the sequence collection seems to adequately rep- 
resent the pattern of Vet gene expression in the tonsillar and 
PB B cell subsets. 
CDRIII Regions.  All sequences had unique V.-D./DIR- 
J. junctions.  D.  and DIR region genes  which could be 
identified between the 3' end of the Vet and the 5' end of 
the J.  genes  are depicted  in  Fig. 4.  The criteria  for the 
identification  of D.(DIP-.) elements in the CDRIII region 
were either (a) 100% homology with a D. or DIR region 
element over a stretch of at least 7 bp, or (b) a single basepair 
difference within a stretch of at least 8 bp that is separated 
by two or more matching nucleotides from the 5' or 3' end 
of a sequence homologous to a D. or DIR region element. 
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CINll  CDRII 
28  29  30  31  '32  33  34  35  45  46  49  51  52  S3  54  55  56  58  59  60  62  64  66  68  69  70  71  73  76  79  81  82  82a 82b 85  8B  89  93  94 
S  F  S  G  Y  Y  N  S  L  E  G  I  N  H  S  G  S  N  Y  N  $  K  R  T  !  S  V  T  N  S  g  L  S  S  A  A  V  A  R 
4.21  TCC  TTC  AGT  GGT  TAC  TAC  TGG  AGC CTG  GAG GGG AT(:  /tAT  CAT  AGT  GGA  AGC /~C  TAC  AAC  TCC  AAG  CGA ACC  ATA  TOt  GTA  ACG AAC  TCC  AAG CTG  AGC  TCT  GCG GCT  GTG GCG AGA 
|GI)I  ....................................  G-  ...........  T  ........................  t  ........................................ 
IG03  ..........................................  -c .................................................................... 
IGO5  ......................................................................................................  - ........ 
]GO~  ...............................................................................  4-  ............................... 
!GO~  ................................................................................................................ 
G042  .............................................................  T  ....  -C  .....................  -C  ........................ 
..........................  t  ...................  A--  ~  .........................  C .............................  A--I 
GO0  .....  t ..........  C-  G-  ...................  -c  .................................................................  ￿9  .... 
......................  C  .........  ￿9  ....................................................  ~-  .....  t ....................... 
(:I)513 ........................................................................  ~  ............................  ￿9  ---c  ......... 
(:05/5  .................................................................................................................... 
~$~  .................................................................................................................. 
CDI1  .................................................  A-  T--  -T  ...............................  -G-  ---  -C-  ............  -c  --- 
Caq3  ..................................................................  G-  ......................  -C-  ............  -c--- 
(~5  ......  ~-  -A-  -T-  --~  ---  ~  ......  a  ---  T--  T--  --c  ......  ~  ~  --t  --t  ---  ~  .............  t  --￿9  ~t  --t  ......  ~-  -~  ............ 
b)  Wt-4 
~  ~x~ 
30  31  32  35  44  49  $0  51  54  56  57  58  59  60  63  64  65  69  70  71  72  76  77  81  82  B2￿9 88  89  91  94 
S  S  Y  S  G  G  Y  I  S  $  T  N  Y  N  L  K  S  |  S  V  O  N  Q  K  L  $  A  V  Y  R 
V71-4  AGT  AGT  TAC  AGC GGA GGG TAT  ATC  AGT  AGC ACC  AAC  TAC  AAC CTC  AAG  AGT  ATA  TCA  GTA ~  ~  ~  ~  ~G  ~  ~  ~  T~  ~ 
~  ...................................................................................... 
I(;04  .......................  -C  .....................................  4-  .......  -c  .............. 
.........  A  ...................................................................  -  .....  t  --- 
......................................................................................... 
C~  ---  -C-  -T-  -C-  --g  ---  A  .........................  C  ..........  t  C  ...........  -G-  ..........  t  --- 
......................  ~  -c  ..........................  ~  .....................  A  ........... 
COS/2  ....  A  ......................  G-  .........  t  ....................................  -C  ........... 
(:I)5/4  ---  CC  ........  -c  --c  ..........  A  ....  -GG  .....  t  T--  C-a  G--  --G  ..........  t  ---  -G- _T-c  -C-  -G-  ......... 
c)  ~) 
a~zx 
28  30  45  49  52  53  54  55  $6  58  59  60  67  69  71  74  76  77  81  82￿9 8g  91  94 
s  s  =  s  s  L  ~  Y  T  S  ~  S  .  Y  N  v  !  v  S  N  0  K  S  V  Y  R 
302790  TCC  AGC GGT  AGT  AGC CTG GGG TAT  ACC  AGT  GGG AGC AAC  TAC  AAC  GTC  ATA  GTA  TCC  AAC  CAG AAG  AGC GTG  TAC  AGA 
mmo  ............................................................................. 
~1  ....  At  ....  ~  ...............................................  t  --T  ............... 
-~  -A  ........................  t  .......................................... 
(:8;1  ..............................  A-  ............  t  ............................... 
....................  ￿9  ......  ~  ..........  ~  .........  A-g  ............  ~  ......  t  --- 
{:05/1  ............................................  -(;  ........................... 
Ga4  ..........  A  ..................................  --G  .......................... 
GOG4  ..........  A  ......  -..-  -T  ..........................  -G  --t  ---  -G-  ---  -G-  ---  T-t  ...... 
GCG8  ---  TC  .............  -Gt ...........  t  lit  lit  All "~  ....  T  .... -4:  ~T  ---  T-c  ..... 
.............  ￿9  ..............................  -(;  ......................... 
f)  VH4.34 
30  ~49  ~'3"~-'~'82￿9 94 
S  G  S  G  Y  S  S  R 
4.34  ~~T~~ 
....  A  ........  t  ....  A- -- 
......  A  ........  t  --- 
g)  3~16 
cml 
30  33  34  35  71  76  78  g4 
S  (;  Y  S  V  N  F  R 
30216  AGC GGT TAC  TCC  GTA  AAC  TTC  AGA 
CI~44  ...................... 
GCG7  ....  A-  --t  --t  ~-  --t  --t  --- 
d) ~  h)  VI~ 
30  42  50  53  60  70  73  78  81  82a88  94  29  4g  51  S3  58  68  81  82a83  94 
S  S  S  Y  G  S  Y  S  S  N  S  T  F  K  S  A  R  !  H  S  G  ]  T  N  T  K  $  T  R 
V2-I  AGCAGTAGTTACGGGAGTTATAGTAGCAACTCCACGTTCAAGAGCGCTAr~  V!V4  ATCTGGAGCGGGATCACCAACACCAAGAGCACCAGA 
..............................  ￿9  .............  -c  ---  ~1  ..........  t  ................ 
"Am  IT .... T-  .....  A--  ~"  ----t  "--t  ........  t  ------  ~  .......  C~  T----  ----A  ----t  ----  ~t  ~  ~--  m--  t  4-  "A--  "T"  --'" 
CBG7  ......  -C  ........  T  ................................ 
(:05/8  ............  A  ......................  ￿9  ....  -T  ........ 
e)  ,~.~ 
30  ~3~  40  4z  49  ~0  s~c~J'Zs7  ~  67  71  73  74  7s  76  el  ~,Lz=e3  89  90  93  94 
SGGS  ]  HGGYYSTYVVTSKNKSVTVYAR 
4.33  AGC GGT  GGT  AG{: ATC  CAC GGG eGG TAC  TAC  AGT  ACC  TAC  GTT  GTA  ACG TCT  AAG  ~  AAG ~  GTG ACT  GTG  TAT  GCG AGA 
Gi{~6  ...........  t  --t  ....  A-  --c  .....  t  -C  ....  CG-  --c  ---  -G-  --c  .....  t  --T  -AG  A--  --c  ---  -G-  -- 
--t  -T-  ~  --t  ..........  -r  --t  ---  ~-  --t  ..................................  ~  ......... 
co~6  .......  A  ..............................  A--  -~  ......  ~  ........................... 
Figure  3.  Comparison of nucleotide  sequences of V.4-encoded transcripts  derived from isolated tonsillar and PB B cell subpopulations.  Y.4 se- 
quences derived from tonsillar IgM § IgD § B cells, IgM- and IgG-exl~essing GCC are abbreviated IGD, GCM, and GCG, respectively. V.4 sequences 
derived from IgM-expressing CD5 +, IgM- and IgG-expressing conventional (CD5-) PB B cells are abbreviated CDS, CBM, and CBG, respectively. 
The sequences are compared with the V.4 gerraline genes (a) V.4.21,  (6) V71-4, (c) 3D279D,  (d) V2-1, (e) V.4.33, (/~ V.4.34, (g) 3D216D, and (h) 
VIV-4. Only those codons of the respective V.4 germline genes that differ from the sequences below are shown. CDR regions and codons are nmn- 
bered according to Kabat et al. (44). (Dashes) Nucleotide identity. (Uppercase  ktters) Replacement mutations,  (Lowercase  letters) Silent mutations.  (Under- 
lined letters) Mutations resulting  in the formation of a stop codon. These sequence data are available from EMBL/GenBank/DDBJ  under accession 
numbers  Z30544-563,  Z30573-581,  7.,30590-600, and Z3(~69-678. 
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ACA  ~  (N)  O  H 
I~I  ---  GGGCAGC  (DLR4)  ATTGTAGTAGTACCAGCTGC  AGGG  AT GCT T'I'T GAT ATC TGG GGC-3b 
IC,02  --- ~T  (DIR11)  T~  CT~TAGGT  GC--4b 
I~3  --- ~  (OIRI)  COC~CACCC  TA  (ONI) Gh'TATAGCJt~Ck~CI"GGTAC  GGCCCCT  "I"1"I"  ~  TAC ~ 
IG04  --- ~TTACA  (I)21-9) ATaAGI"AT~  ~  Tvr ~T  ATC T~  GGC~3b 
IGD5  (OLR1AI)  AI-rAGTAC  TTTGGGC  TAC TAC GGT A'IG GAC GTC TGG G~?,--6b 
IGD6  ---  CAATCGCGT  (PNDE) C,-,GCTTGG  AT GCT TIT GAT ATC TGG GGC-3b 
IG~  ---  ACGG  (D.-r~w)  TAGTGG~cCT  CATG  AT GCl" TTT GAT Arc TGG GGC--3b 
IGD9  CCAA  (ON1)  GGcAT~AC  CCTTrGTTT TAC TAC GGT ATQ GAC GTC TGG GGC-6b 
IGDIO  ---  GGCCTGAC  (D21-9)  GTAI"I"ACTATGATAGTAGTGGT'rATTAC  AGGGAAT  AC TAC 1"1"T GAC TAC TGG NNN-4b 
C-g~l  ---  GGGGTGACGTCG  (11411) AT~GGT  CCACGC  TAC TAC GcT ATG CAC GI"C TGG GGC-Sb 
---  GGCCI~(~W (ONe,) GTATAGCAGCTCG COGC (I)23..-7) GCAI-ITi'gGG CCTCTCTCGC  TAC TAC ATG GAC GTC TGG GGC-6c 
GCH3  ---  GATGT(~"TAT  (021-9)  TTACcATC~T~'TAGTGcTIATrAC  (0Kll)  OCACTAT  ~  G~'.-4b 
GO44  ---  AGGGGGGG  (DKI)  GGCTACGATr  GG  TIT GAC TAC TGG C-:-:-:-:-:-:-:-:-:~C-4b 
G(3~45  --~  GGCI~'TGTI'CAC (DNIp)  ATAGCAGTGGCTGGT  C  (DIR1)  GCCTCAA  ATATG  AT GGT TiT GAT ATC TGG GGC-3b 
---  GG~'TOgAAC  (O21-7)  GTTCGGgaAal"I'AT  TAC cTT GAC TAC TGG G~-.-4b 
C43ff7  ATCAA  (DXP1) TrrGA~--T  TC GgT CTC TGG G~C-2 
C.,O4B  ---  GCGGG  (DXP1)  ACCATAI"rTI'CACTGG  C4~"TAI"I'CATGGGGC  GCT TTT GAT ATC TGG GGC-3b 
GCG1  --  40K4't)  _AGf.TGTATC  GGGAC 4DK1) GT~Oq~r  TC  TAC TAC ATG GAC GTC TGG GGC-~:: 
GCG2.  --  ~  4DLRIA) ATATTGTACTAATGGTGTATGC'rAT  C  I"I" GAC TAC TGG 
GCG3  ---  GCGCGC  (DLR2)  TGTgaT~CTAC  ~T  TAC TAC ATG CAC GT~ TGG GGC-6c 
GCG4  ---  GATGTrCAC  (DXP'I)  ATrAaTATGa~TrAcTA  CI  TAC ATG GAC GTC TGG GGC--6c 
GCG5  (PNDE) GGCTTGGG  ACCGTGGA  AC TAC TTT CAC TAC TGG GGC-4b 
GCG6  --  GCA  (DXP4) GTATTACGAI  fIIIGGAGTG  CCT~  TTT GAT ATC TGG G~-3b 
GCG7  ---  GTATOGCAA  (DLR4)  TGTAGTAGTAO~tGCTGCTA  CGQGCAGA  TT CAC TAC TGG G~2--4b 
GCC~  ---  GGGCCAGCGGAC  (D21-7)  TTCGGtcA  CCTCGGGTTCC  AC TTT GAC TAC ~  GGC--4b 
CD5/I  ---  GATGAT  40NIp)  GGTATAGCAGTGGCTGGTAC  AGAGGAA~..rT  TTT GAC TAC TGG ~d,/-4b 
CDS/2  A/kGG~G  (DNI)  GCAGCTGGTAC  GGGGI-rGc  TTa K~ 0~ TGG GGC-5b 
C05/3  ---  GA  (DKI)  CTACGgTgAC  T  AT GCT TTT CAT ATC T~  GGC-3b 
CDS/4  ---  CTACACAGI"I'ATGGTC  (D21-10)  T~  C GAC CCC T~  ~O-Sb 
(;05/5  ---  GGCTT  (DN4)  TAGCAGCTCGTCC  GGGAGGGGGG'I'r  TAC TAC ATG CAC GTC TGG GGC.-6c 
CDS/6  --  T  (DN4)  TATgGCAGCTC  TAG  C TTT GcC TAC T~  I~C-4b 
CDS/7  --  CCGCACATTCA  (D21-10)  ~____~_J6T  CACCTACTAAGTCCGC  TT GAC TAC TGG NNC-4b 
C05/8  --  (D22-12i)  A~tGq'CCAA  (01R2t)  GGt.ogCTGGACAG  GGT  AC TAC TTT GAC TAC TGG NNN-4b 
~I  --- GGT~'I'FTC.-C=A  (DLR4)  TAGTACCAaCTGtTAT  TACTACTTGGGA  TI"T GAC TAC TGG NNC-.4b 
CB,~  GGAAAACCTCC  (DN1)  GGGTAT~GG  C,C-~TACAG  TGG TAC TTC CAT CTC TGG GGC-2 
C81,L3  ---  GGGTGG  (DLR4)  ATTGTt.GTAGTtaCAGCTcCT  TIT CAC TcC TGG ~Jr 
CBM4  ---  GACTTC  CAT ATC TGG GGC-3b 
CEM5  ---  TACGCACA  4DA1) TGACTACAGTAACTAC  CCAAGGGATC  AC TAC GGT ATG CAC GTC TGG GGC-6b 
---  GG  (DLR5)  ACgACTTTC  (OXP4)  GC~I~ffI'C-iG  CTC.~Cd~  ~  TTC GAC CCC TGG GGC-5b 
CB,T7  ---  ACGTATCTCAC  4021-9)  GTATTACTATCATAGTAGTGGTTAT  CC  C TIT CAC TAC TGi,  I  NNC-4b 
C8~  ---  CA  40XP'l'I)  ~  CT  TGG TAC TTC CAT CTC TGG GGC-2 
--  CGCT~CTTAGAGA  (DK1)  TGGCTACaATT  TATGGGG 
C  _  _.-"#2J~_  _JLXT~G  (D21-9t)  GT99TAACCAC  C 
---  TTCGG'I'GTGTCC,-.CAGTGC.~  (DIR1)  GClTCGTC~_ 
---  CATGGCC~  (DK1)  GTGaCTACGATr  TCCA 
--  GTGGA1"rCCCC  (PNOE)  GGc'FrGGG  (0IR1)  Gr.~c  G 
GGATCAGC  (DXP'I) (~ATAGT  A 
---  CGGGG  41)I(4) GCAT/tCA  TC 
---  GCTAG  (DXPI) ~TA~cAI-rAT  CCG;I'GC,,CA 
---  CATGTG  (D-new)  AGTGGGAGCTACT  TTGGTGTTGG 
CBG1  C TAC T~ GQC-.4b 
TAC TC~ TAC TTC CAT crc T~ ,~C-2 
C8G3  T GoT TTT GAT ATt T~ ~o-3b 
CBG4  AC TrT ~  TAC TC~ G~,.-4b 
C8G5  C T'IT GAC TAC TGG GGC.-4b 
C8G6  AT GCT TTT CAT ATg TGG C~C-3b 
CBG7  C TGG TAC TTC GAT CTC TGG GGC-2 
CGB8  GCT TIT CAT "ccC TGG GGC-3b 
CBG9  T TTT GAc ATC TGG GGC-3b 
Figu~  4.  Nudeotide sequences 
of CDRIII regiom of rearranged 
V.4  genes  derived  from  isolated 
tonsillar and PB B cell subpopuh- 
fions.  Clones are designated as in 
Fig.  3.  Indicated  are  the  Y  end 
(codon 94) of the respective V.4 
gene. N region nucleoti&s  (N), D. 
and/or DIR region elements (/~), 
aM the 5' end of the rearranged  J. 
genes (42, 43). D. aM/or DIR re- 
gion elements (45-50) which could 
be identified in between the 3' end 
of Vs4 aM the 5' eM of J. are in- 
dicated. (PNDE)  Presumptive new 
D.  element. (Dashes) Nucleotide 
identity. (N) Sequence ambiguities. 
(i)  Inverted orientation  of the re- 
arranged D.  or DIR  region  de- 
ment. (L,  owe~ase/etten) Nudentide 
difftrences  to  the  corresponding 
D., DIP., or J. elements. (Under- 
lined letters) Nuchotides are derived 
either from the D./DIR element 
or from the corresponding V.4 or 
J. gene segments.  These sequence 
data  are  available from  EMBL/ 
GetLBank/DDBJ  under  accession 
numbers Z30544-563, Z30573-581, 
Z30590-600,  and Z30669-678. 
Using these criteria, in 47 of 50 clones, one or two published 
D.  or  DIR  region  genes  (45-50)  could  be  identified. 
Nucleotide sequences within the  joining regions of three clones 
(IGD6, GCG5, and CBG5) which could not be assigned to 
any of the published D.  or DIR region elements showed 
100% homology over a stretch of seven nudeotides (CCA- 
AGCC). This sequence might represent a part of a novel D. 
or  DIlL  region  element  and was  accordingly  designated 
presumptive  new D. element or PNDE (Hg.  4).  CDRIII 
regions of 41 clones (82%) harbored one, those of right clones 
(16%)  harbored  two D.  or DIR  region genes.  Although 
most D./DIR region elements were rearranged in the usual 
orientation, CDRIII regions carrying inverted D./DIR re- 
gion elements (2,  43) were occasionally  seen. 
The average length of the CDRIII region (codon 95-102) 
was  determined  to  be  40  nucleotides  and  did  not  vary 
significantly among the fractions (IGD, 39 bp; GCM, 43 bp; 
GCG, 45 bp; CD5, 37 bp; CBM, 39 bp; and CBG, 37 bp). 
N  region nucleotides within the V.-D.  and D.-J. joints 
could be identified in most of the clones (Fig. 4). No significant 
differences in terms of occurrence of N  region insertion at 
the V.-D. or D.-J. junctions as well as length of N regions 
were observed among the fractions. All but two (IGD2 and 
GCM4) of the V.4 sequences were in frame. One V.4 se- 
quence  (CBM6)  showed  a  G  to  A  nucleotide  exchange 
resulting in the formation of a stop codon (Fig.  3 h). This 
exchange might be caused by misincorporation in the PCP.. 
Somatic Mutation in TonsiUar  and PB B Cell Subsets.  Table 
1 summarizes  the nudeotide 'differences in the rearranged 
V.4 and J. genes compared to the germline genes to which 
they showed highest homology. Table 2 shows the V.4 and 
J. gene mutation frequencies  determined  for the respective 
fractions.  A  PCR nucleotide misincorporation error of 1/ 
585 bp was subtracted from the values  (4). 
1388  Memory B Cells Accumulate in the Peripheral Blood Already at Young Age Table  2.  Summary of Mutations in Rearranged V,,# and J~ Genes Expressed in  Tonsillar and PB B  Cell Subsets Derived 
from a 4-~-old Child 
V~4  J. 
Origin  Cell popuhtion  No. clones  Range  % Mutation  Range  %  Mutation 
IGD  9  0-3  0.4  0-1  0.0 
Tonsil  GCM  8  1-10  2.0  0-1  0.7 
GCG  8  1-13  3.3  0-3  1.2 
CD5 and CBM*  10  0-3  0.35  0  0.0 
Peripheral  CD5* and CBM*  5  3-11  2.6  0-1  1.7 
blood  CBG  9  1-22  3.2  0-4  3.3 
* v.4 transcripts derived  from IgM-expressing  CD5 + and CD5- PB B cells were analyzed  together. Mutation frequencies  were determined  for V~4 
transcripts that showed (a) three or less, and (b) four or more mutations relative to the corresponding VH4 and J. germllne genes. 
* The V.4 sequence  of clone CD5/4 was excluded from the mutation analysis. Cell populations are designated as in Table I. 
Tonsillar  IgM-  and  IgG-expressing  GCC  showed V.4 
gene mutation frequencies of 2.0 and 3.3%, respectively (Table 
2). The corresponding frequency (3.2%) determined for IgG- 
expressing PB B cells was in the same range as that deter- 
mined for IgG-expressing GCC. 
The V.4  gene mutation frequency determined for ton- 
siUar IgM+IgD + cells was 0.4%.  V.4  transcripts  derived 
from CD5 + and conventional (CDS-) IgM-bearing PB B 
cells were analyzed together (see Discussion).  Whereas all 
V.4  rearrangements derived from tonsiUar IgM+IgD + B 
cells  showed three or less mutations relative to the corre- 
sponding VH4 and JH germline genes, 5 of 15 V.4 transcripts 
(excluding  CD5/4,  see  above)  derived  from  CD5 +  and 
CDS-  IgM-expressing PB B cells harbored more than three 
mutations (range of mutations per gene, 4-12; Table 1). Since 
in the PB/~ chain transcripts presumably originate from two 
distinct B cell subsets (4), mutation frequencies were deter- 
mined for V.4 transcripts from IgM-bearing PB B cells that 
showed (a) three or less mutations, which corresponds to the 
range of mutations observed in tonsillar IgM+IgD + cells, 
and (b) four or more mutations in the rearranged V,4 and 
J~ genes. The corresponding V~4 gene mutation frequencies 
were 0.35  and 2.6%,  respectively (Table  2). 
To confirm the virtual absence of somatic mutation in 
VH4 transcripts derived from tonsillar IgM+IgD + B cells, 
nine V~ rearrangements were amplified with V~3 and V~4 
family specific primers from genomic DNA isolated from this 
fraction. Recently, all V~ germline genes have been ordered 
and sequenced (51). They seem to exhibit little polymorphism, 
thus allowing the identification of somatic mutations in re- 
arranged V, genes.  Three of the V~ rearrangements were 
nonproductive (data not shown; the sequence data are avail- 
able from EMBL/GenBank/DDBJ under accession numbers 
Z30564-572).  The V~ transcripts  harbored 0-4-bp  differ- 
ences  in  the  rearranged  V~  and J~  gene  segments  (not 
shown), yidding a mutation frequency of 0.2% (a PCR error 
of 1/585 was subtracted from the value [4]). This frequency 
is in a similar range as that obtained for V.4 transcripts de- 
rived from tonsillar IgM+IgD + B ceils (0.4%). 
Discussion 
V~4 Gene  Usage.  So far,  not all potentially functional 
V.4 germline genes have been found in rearranged antibody 
V genes. In addition, particular V.4 gene segments appear 
to be overrepresented over other members of this gene family 
as judged by their frequent appearance in independent analyses. 
Among the 50  V~4  sequences obtained in  the present 
work, three gene segments were found to be overrepresented: 
V.4.21 (30%), V71-4 (20%), and 3D279D (20%) (3D279D 
presumably represents an allelic form ofV71-2 [30, 39]). These 
three genes belong to the group of VH4 genes which in the 
past were repeatedly found to be expressed in peripheral B 
ceils. In particular, the V.4.21 gene segment was frequently 
seen in stir-reactive antibodies in various autoimmune dis- 
eases (52 and references therein). VH4.21-bearing  antibodies 
are known to recognize autologous determinants on red blood 
ceils, the I/i antigens, and such antibodies are found in the 
serum of healthy individuals (for a review see reference 52). 
The observation that 30% of the clones in our sequence col- 
lection carried V~4.21, together with the recurrent finding 
of V. and VL gene segments that  are associated with an- 
toreactivity in PB B ceils of normal individuals (for a review 
see reference 53),  implies that a considerable proportion of 
the antibody repertoire in normal individuals contains "anti- 
selP' specificities,  as previously suggested (54).  V71-4- and 
V71-2-bearing antibodies also appear to be associated with 
autoreactivity (52,  53).  However, we cannot rule out that 
the overrepresentation of V~4.21, V71-4, and 3D279D tran- 
scripts in the cDNA libraries is the result of higher Ig-mRNA 
contents in B ceils expressing these gene segments, although 
we  consider  this  an  unlikely  possibility.  A  preferential 
amplification of these V,4 gene segments in the PCK seems 
also unlikely since the V~4FKI-primer used in the present 
1389  Kldn et al. study exhibits 100% homology to the corresponding sequence 
in nearly  all V.4  germline genes (see also  Materials  and 
Methods). That the PCR amplification does not lead to an 
overrepresentation of particular V.4  genes in  the cDNA 
lihraries is further supported by the differing V.4 gene usage 
between fractions. 
10 different V.4 genes were found to be expressed in the 
present individual. Ac.cordingly, on the assumption that the 
number of potentially functional V.4 genes in the haploid 
genome of an individual is 9-11  (26,  29, 30),  most of the 
genes of this family were expressed. This contradicts recent 
suggestions that at the level of V. gene usage the expressed 
antibody repertoire is considerably smaller than the available 
repertoire (55,  56),  at least  at  the level of the V.4 gene 
family. 
In summary, it appears that most V.4 germline genes are 
expressed in peripheral B cells. However, some members of 
this family are clearly overrepresented over others. It remains 
to be seen whether this picture can be extrapolated to the 
other V  gene families. 
Differences of V.4 gene usage between fractions were par- 
ticularly evident in the case of the tonsillar B cell subsets: 
whereas IgM+IgD -  GCC as well as tonsillar IgM+IgD + 
cells exclusively expressed  V.4 genes which could be as- 
signed to one of the three overrepresented gale segments (8/8), 
most V.4 transcripts (5/8) derived from IgG + GCC showed 
highest homology to one of the genes which were found only 
rarely in the present analysis (Table 1). This differing V.4 
gene usage among the tonsiilar B cell subsets is likely to reflect 
antigenic selection within the GC  microenvironment. A 
striking observation was that of the 15 clones which carried 
a  V~4.21 gene,  13  originated from  IgM-expressing cells 
(13/33,  39%) whereas only two were found among IgG- 
expressing GCC and PB B cells (2/17, 12%). This gene seg- 
ment was particularly overrepresented in transcripts derived 
from tonsillar IgM+IgD §  (naive) B  cells (5/9),  but was 
found in only 1/9 transcripts derived from IgG + (memory) 
PB B cells. It appears that V.4.21 is only rarely used in T 
cell-dependent immune responses  to exogenous antigens. 
In addition to the restricted usage of V.4 gene segments 
in the tonsillar IgM +  IgD + naive B cells, the J.3 gene seg- 
ment seems to be overrepresented (4/9) in this population. 
A high frequency of J~3 utilization is a feature of fetal Ig 
rearrangements (2, 57,  58).  However, other characteristics 
of the fetal B cell repertoire, namely a high usage of the most 
proximal D, element, D.Q52,  short CDRIII lengths and 
a low frequency of N  region addition (2, 57, 58) were not 
observed in V  region genes derived from tonsillar IgM + 
IgD + cells. 
Naive IgM +  IgD + B Cells Express Virtually Unmutated V 
Region  Genes.  Tonsillar  IgM+IgD +  B  cells,  which  are 
localized in the mantle zone surrounding the GC and the 
interfollicular area, express V region genes with no or little 
somatic mutation. The low V~4 gene mutation frequency 
in this population (0.4%) is similar to that determined for 
J. regions (0.0%) and rearranged V~3 and V~4 genes carried 
by the same cells (0.2%; the latter genes were amplified from 
genomic DNA). No or little somatic mutation was also ob- 
served in mantle zone B cells (most of which express IgD) 
derived from human lymph nodes (9). We have previously 
shown that IgM+IgD + PB B cells from a 67-yr-old person 
likewise  express virtually unmutated V, genes (4).  These 
cells comprise the majority ofPB B cells throughout life and 
represent a large B cell subpopulation in secondary lymphoid 
organs. 
Thus, as we had already concluded from our earlier data 
(4), the repertoire of human naive IgM+IgD + B cells is de- 
termined by germline-encoded specificities and by generation 
of variability  in CDKIII through V.-DH-J. recombination 
throughout life, like in the mouse (3). 
Tonsillar IgM+IgD -  and IgG + GCC Express Somatically 
Mutated V  Region Genes,  Ongoing somatic mutation in 
human GCC has recently been demonstrated for GCC picked 
from histological sections of lymph nodes (9). In the present 
analysis, purified tonsillar GCC were distinguished on the 
basis of IgM and IgG expression. Both IgM- and IgG-bearing 
tonsillar GCC express somatically  mutated antibody genes 
(2.0  and 3.3%  V.4 gene mutation, respectively).  The in- 
creased  V.4  gene  mutation frequency of IgG-expressing 
GCC compared to IgM-expressing GCC could imply that 
the former ceils represent B ceils at a later stage of the GC 
reaction. This assumption is supported by the differing V.4 
gene usage between these subsets. 
Somatically Mutated IgM- and IgG-bearing PB B Cells Prob- 
ably Represent GC-derived B  Cells,  Since no drastic differ- 
ences in terms of somatic mutation were observed between 
the IgM-bearing CD5 + and conventional (CDS-) PB B cell 
subpopulations-in agreement with results obtained for the 
corresponding B cell subsets in adults (19)-they are not dis- 
cussed separately. One third of the V.4 sequences (5/15) de- 
rived from these populations harbored more than three mu- 
tations  (a  0-3-bp  difference  corresponds to  the range  of 
mutations observed in tonsiUar IgM +  IgD + cells) relative to 
the corresponding V.4 and J. germline genes (4-12 muta- 
tions; Table 1), yielding a Vh4 gene mutation frequency of 
2.6% (Table 2). On the other hand, the frequency determined 
for the V.4 transcripts harboring three or less mutations in 
the rearranged V.4 and J. genes was in the same range as 
that  determined for  tonsillar  IgM+IgD +  cells  (0.35  and 
0.4%, respectively). Somatically mutated/~ chain transcripts 
have previously been found in PB B lymphocytes from adults 
(14, 16, 18, 19). Such transcripts are most likely to be de- 
rived from IgM +  IgD-  ceils, which, in contrast to IgM + 
IgD + cells, express V  region genes diversified by somatic 
mutation (4). 
The mutation frequency determined for V~3 transcripts 
of IgM+IgD -  PB B cells (4) is similar to that determined 
for  V.4  transcripts  of  IgM+IgD -  GCC  (see Table  2; 
"~2.0% in both cases). These observations indicate that the 
IgM+IgD -  PB B cell subpopulation is composed of GC- 
derived B cells that have left the GC at an early stage of the 
GC reaction without undergoing isotype switching. 
IgG + PB B cells are thought to be GC-derived memory 
B cells. The specific analysis of PB memory B cells in indi- 
viduals of various ages allows one to determine somatic mu- 
tation frequencies in these cells regardless of their actual per- 
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mutation in IgG §  cells  from the child investigated in the 
present  work  and  IgM-IgD-  cells  (mostly representing 
IgG + and IgA + B cells) from a 67-yr-old person (4) indi- 
cates that the mutation frequency (3.2 versus 3.9%) in PB 
memory B cells does not increase significantly with age. To- 
gether with the fact that the VH4 mutation frequencies de- 
termined for IgG-expressing GCC  and  IgG +  PB  B  cells 
were in the same range (3.3 and 3.2%, respectively) this im- 
plies that long-lived memory cells do not acquire additional 
somatic mutations after they have left the GC. 
Somatically Mutated IgM + and IgG + B Cells Accumulate in 
the  PB  during  Life.  Recent  experiments by  Bridges  and 
Schroeder indicate that the fraction of somatically mutated 
r  light chain transcripts amplified from PB B lymphocytes 
increases with age (Bridges, S. L., and H. W. Schroeder, Jr., 
personal communication, and 58a).  These transcripts were 
most likely derived from both IgG- and IgM-bearing B cells. 
At the time of birth, IgM-bearing B cells express virtually 
unmutated V region genes (16, 17), mirroring the situation 
in the fetal liver (57, 58, 40) (an exceptional case has been 
reported by Cuisinier et al. [40] who found somatically mu- 
tated V.6 transcripts derived from fetal liver B cells). How- 
ever, the hypermutation mechanism is already active at this 
time of ontogeny as indicated by the finding of somatically 
mutated 3' and tx chain transcripts derived from cord blood 
B lymphocytes (22). 
These observations, together with our finding of mutated 
3, and/z chain transcripts in PB B lymphocytes already at 
young age, suggest that IgG + as well as IgM+IgD -  B cells 
expressing somatically mutated V region genes accumulate 
in the PB during ontogeny. Thus,  the age-related increase 
of somatic mutation in PB B cells observed by Bridges and 
Schroeder probably reflects an increase in the percentage of 
somatically mutated B cells among PB B lymphocytes since 
the mutation frequencies in these cells do not appear to vary 
significantly with age. 
Sequence analyses of V gene transcripts derived from PB 
B lymphocytes of adults showed that the majority of# chain 
(14, 16, 18, 19) and r light chain transcripts (Bridges, S. L., 
and H. W. Schroeder, Jr., personal communication, and 58a) 
were somatically mutated.  This  is  surprising  since naive 
IgM +  IgD + B cells represent the major B cell population in 
the PB throughout life (4), comprising at least 70% of PB 
B  lymphocytes.  This  discrepancy might  be  explained by 
differing Ig-mRNA  levels  in  the  various  B  cell  subsets, 
resulting in an overrepresentation of transcripts derived from 
IgM+IgD -  and dass-switched B  cells in cDNA libraries. 
The same might be true for the recent findings that the vast 
majority of V~ transcripts derived from splenic B cells of old 
individuals were somatically mutated (Bridges, S.  L.,  and 
H. W. Schroeder, Jr., personal communication, and 58a, 59). 
In conclusion, the human PB B cell repertoire is composed 
of at least three B cell subsets which can be distinguished 
according to their isotype expression and according to the 
extent of somatic mutation found in their rearranged V genes. 
Naive IgM +  IgD + B ceils -  presumed precursors of GCC- 
express germline specificities and remain the major PB B cell 
subset  throughout  life.  Somatically  mutated  IgM+IgD - 
ceils, as well as class-switched memory B calls,  seem to be 
constantly generated in GC and accumulate in the PB in the 
course of life. 
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